Arkolith/Insider Trading/CAI/Form 4

Brille Brian J

See Remarks, DirectorCaris Life Sciences, Inc. (CAI) · full profile →Form 4 · filed Jun 23, 2025
Net Buying
Open-Market Buys
$630K
Open-Market Sells
$0
Net Open-Market Flow
$630K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2025Buy(P)30K$21.00$630K162K
Jun 18, 2025Grant(A)132K—$0132K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-061802) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML